Generic Drug Co. Can't Kill Merck IP Suit Over Antifungal
A New Jersey federal judge ruled Monday that Merck & Co. Inc. has a valid patent covering fungal infection treatment Cancidas, allowing a patent infringement suit the drug giant lodged against...To view the full article, register now.
Already a subscriber? Click here to view full article